Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|December 28, 2002
Molecular basis of the antitumor activities of 2-crotonyloxymethyl-2-cycloalkenonesErin Joseph, Julie L Eiseman, Diana S Hamilton, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2004
Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenograftsJulie L Eiseman, Jing Lan, Theodore F Lagattuta, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2008
Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in miceJianxia Guo, Robert A Parise, Erin Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
A mass balance and disposition study of the DNA methyltransferase inhibitor zebularine (NSC 309132) and three of its metabolites in miceJan H Beumer, Erin Joseph, Merrill J Egorin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2006
Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in miceJan H Beumer, Julie L Eiseman, Robert A Parise, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 1, 2019
Confirmation of Selected Synergistic Cancer Drug Combinations Identified in an HTS Campaign and Exploration of Drug Efflux Transporter Contributions to the Mode of SynergyStanton J Kochanek, David A Close, Allen Xinwei Wang, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2002
Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 ratsMerrill J Egorin, Theodore F Lagattuta, Deborah R Hamburger, et al.
Advances in Biological Chemistry|September 12, 2017
Evaluation of Silicon Phthalocyanine 4 Photodynamic Therapy Against Human Cervical Cancer Cells In Vitro and in MiceJill A Gadzinski, Jianxia Guo, Brian J Philips, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2015
Characterization of the metabolism of benzaldehyde dimethane sulfonate (NSC 281612, DMS612)Robert A Parise, Julie L Eiseman, Dana M Clausen, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2015
In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of pyrazole-based small molecule inhibitors of Mdm2/4-p53 interactionSusan M Christner, Dana M Clausen, Jan H Beumer, et al.
Pageof 7